SARS-CoV-2 infection and male fertility problems

Ika Inda Bani, Zulkarnain Zulkarnain, Gholib Gholib, Dedy Syahrizal, Fauzul Husna, Winda Yulia, Mulkan Azhari

Abstract


In 2019, the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has killed more than 6.6 millions of people around the world as of end of 2022. The long-term impact of COVID-19 is persisted, including its impact on male reproduction. SARS-CoV-2 enters into host cells using the angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) receptors. Both of these receptors are expressed more in men, and therefore men are more susceptible to SARS-CoV-2. COVID-19 potentially cause infertility by damaging testicular tissues and interfering with the process of spermatogenesis. A decrease in serum levels of testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) as well as a decrease in sperm quality in men with COVID-19 compared to healthy men of the same age has been reported in several studies. Utilizing existing research data, this study aims to explore in detail of how SARS-CoV-2 tends to affect male fertility.


Full Text:

PDF

References


Bechmann N, et al. COVID-19 Infections in Gonads: Consequences on Fertility? Hormone and Metabolic Research 2022.

Bisht S et al. Oxidative stress and male infertility. Nature Reviews Urology 2007; 14(8):470–485.

Boopathi S, et al. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics 2021; 39(9):3409-3418.

Chen Y-W, et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. The American journal of pathology 2010; 176(6):2986-2996.

Cinislioglu AE, et al. The relationship of serum testosterone levels with the clinical course and prognosis of COVID‐19 disease in male patients: A prospective study. Andrology 2022; 10(1):24-33.

Delgado-Roche L and Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Archives of medical research 2020; 51(5):384-387.

Di Mascio D, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. American journal of obstetrics & gynecology MFM 2020; 2(2):100107.

Ding Y, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 2004; 203(2):622-630.

Donoghue M, et al. A novel angiotensin-converting enzyme–related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation research 2000; 87(5):e1-e9.

Douglas GC, et al. The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology 2004; 145(10):4703-4711.

Dutta S, et al. Reproductive inflammatory mediators and male infertility. Chem. Biol. Lett 2020; 7(2):73-74.

Fan C, et al. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. MedRxiv 2020.

Gacci M, et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Human Reproduction 2021; 36(6):1520-1529.

Glowacka I, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of virology 2011; 85(9):4122-4134.

Guan W-j, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine 2020; 382(18):1708-1720.

Hermann BP, et al. The mammalian spermatogenesis single-cell transcriptome, from spermatogonial stem cells to spermatids. Cell reports 2018; 25(6):1650-1667. e1658.

Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell 2020; 181(2):271-280. e278.

Holtmann N, et al. Assessment of SARS-CoV-2 in human semen—a cohort study. Fertility and sterility 2020; 114(2):233-238.

Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet 2020; 395(10223):497-506.

Hulswit RJ, et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proceedings of the National Academy of Sciences 2019; 116(7):2681-2690.

Jan SZ, et al. Unraveling transcriptome dynamics in human spermatogenesis. Development 2017; 144(20):3659-3673.

Jiang S, et al. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends in immunology 2020; 41(5):355-359.

Ko C-J, et al. Androgen-induced TMPRSS2 activates matriptase and promotes extracellular matrix degradation, prostate cancer cell invasion, tumor growth, and metastasis. Cancer research 2015; 75(14):2949-2960.

Koc E and Keseroğlu BB. Does COVID-19 worsen the semen parameters? Early results of a tertiary healthcare center. Urologia Internationalis 2021; 105(9-10):743-748.

Letko M, et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature microbiology 2020; 5(4):562-569.

Li H, et al. Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine 2020; 28:100604.

Li X, et al. COVID-19 and Male Reproduction: A Thorny Problem. American Journal of Men's Health 2022; 16(1):15579883221074816.

Ma L, et al. Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study. MedRxiv 2020.

Ma L, et al. Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients. Journal of medical virology 2021; 93(1):456-462.

Maleki BH and Tartibian B. COVID-19 and male reproductive function: a prospective, longitudinal cohort study. Reproduction 2021; 161(3):319-331.

MascioD et al. Systematic Review Outcome of coronavirus spectrum infections. AJOG 202: 1–9.

Millet JK, et al. Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage. PLoS One 2012; 7(11):e49566.

Ortega JT, et al. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI journal 2020; 19:410.

Rastrelli G, et al. Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients. Andrology 2021; 9(1):88-98.

Schuppe H-C and Meinhardt A. Immune privilege and inflammation of the testis. Immunology of gametes and embryo implantation 2005; 88:1-14.

Sengupta P, et al. Reproductive tract infection, inflammation and male infertility. Chemical Biology Letters 2020; 7(2):75-84.

Shantanam, S. Structure, Function, and Evolution of Coronavirus Spike Proteins. The Annual Review of Virology 2018;176(1): 139–148.

Shastri A, et al. Delayed clearance of SARS-CoV2 in male compared to female patients: high ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs. MedRxiv 2020.

Shen LW, et al. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie 2017; 142:1-10.

Simmons Z L and Roney JR. Androgens and energy allocation: Quasi-experimental evidence for effects of influenza vaccination on men’s testosterone. American Journal of Human Biology 2019; 21(1):133–135.

Temiz MZ, et al. Investigation of SARS‐CoV‐2 in semen samples and the effects of COVID‐19 on male sexual health by using semen analysis and serum male hormone profile: A cross‐sectional, pilot study. Andrologia 2021; 53(2):e13912.

Tortorici MA and Veesler D. Structural insights into coronavirus entry, Advances in virus research. 2019. Elsevier, pp. 93-116.

Tortoricia MA and Veesler D. Structural insights into coronavirus entry. Resuscitation 2022; 151:59–66.

Trypsteen W et al. On the whereabouts of SARS-CoV-2 in the human body: A systematic review. PLoS Pathogens 2020; 16(10): 1009037

Van Der Made CI et al. Presence of Genetic Variants among Young Men with Severe COVID-19. JAMA 2020; 324(7):663–673.

Vlasak R, et al. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proceedings of the National Academy of Sciences 1988; 85(12):4526-4529.

Wang Z and Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells 2020; 9(4):920.

World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 11. 2020.

Zhou P, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature 2020; 579(7798):270-273.




DOI: https://doi.org/10.24815/tigh.v2i2.29426

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.



2021 | Trends in Infection and Global Health (TIGH)